International Implications of 35 U.S.C. Sec. 271(e)(1), the “Safe Harbor” Provision of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch/Waxman Act), American Chemical Society Annual Meeting
This event has already occurred.
Related Insights
CBER Director Resigns from FDA, Commissioner Makary’s Recent Remarks on FDA Staffing Cuts, CBER Hiring Data, and Additional Leadership Developments